Table 1. Overview of considered hallucinogenic drug agents.
IV, intravenous.
| Drug chemical class | Drug name | Drug effect class |
Number of
testimonials |
Estimated
duration |
Average
duration (hours) |
Dosage range |
Route of
administration |
Source |
| Tryptamine | 5-MeO-DMT | Psychedelic | 282 | 5–20 min | 0.2 | 2–15 mg | Smoked | erowid.org |
| DMT | Psychedelic | 531 | 5–20 min | 0.2 | 15–60 mg | Smoked | ||
| DPT | Psychedelic | 148 | 2–4 hours | 3 | 100–250 mg | Oral | ||
| Psilocin | Psychedelic | 597 | 3–6 hours | 4.5 | 10–20 mg | Oral | ||
| 5-MeO-MiPT | Psychedelic | 71 | 4–6 hours | 5 | 2–7 mg | Oral | ||
| 5-MeO-DiPT | Psychedelic | 208 | 4–8 hours | 6 | 6–12 mg | Oral | ||
| DiPT | Psychedelic | 54 | 6–8 hours | 7 | 25–100 mg | Oral | ||
| 5-MeO-TMT | Psychedelic | 109 | 5–10 hours | 7.5 | 75–150 mg | Oral | ||
| Phenethylamine | 2C-D | Psychedelic | 47 | 4–6 hours | 5 | 20–60 mg | Oral | |
| 2C-B | Psychedelic | 204 | 4–8 hours | 6 | 10–35 mg | Oral and insufflated | ||
| 2C-C | Psychedelic | 64 | 4–8 hours | 6 | 20–40 mg | Oral | ||
| 2C-T-2 | Psychedelic | 118 | 6–8 hours | 7 | 12–25 mg | Oral | ||
| 2C-P | Psychedelic | 58 | 5–10 hours | 7.5 | 6–10 mg | Oral | ||
| 25I-NBOMe | Psychedelic | 150 | 6–10 hours | 8 | 50–1200 mcg | Oral | ||
| 2C-I | Psychedelic | 391 | 6–10 hours | 8 | 14–22 mg | Oral | ||
| 2C-E | Psychedelic | 303 | 8–12 hours | 10 | 10–25 mg | Oral | ||
| Mescaline | Psychedelic | 136 | 10–12 hours | 11 | 200–400 mg | Oral | ||
| 2C-T-7 | Psychedelic | 173 | 8–15 hours | 11.5 | 10–30 mg | Oral | ||
| Lysergamide | LSD | Psychedelic | 1173 | 5–12 hours | 8.5 | 50–200 mcg | Oral | |
| Diterpenoid | Salvinorin A | Dissociative hallucinogen |
199 | 5–30 min | 0.3 | 200 mcg–1 mg | Smoked and oral | |
| Arylcyclohexylamine | Ketamine | Dissociative anesthetic | 405 | 45–90 min | 1 | 100–500 mg | Insufflated, oral, and IV | |
| Amphetamine | MDA | Entactogen | 79 | 4–6 hours | 5 | 80–160 mg | Oral | |
| MDMA | Entactogen | 1155 | 4–6 hours | 5 | 80–150 mg | Oral | ||
| DOM | Psychedelic | 36 | 14–20 hours | 17 | 3–10 mg | Oral | ||
| DOI | Psychedelic | 34 | 16–30 hours | 23 | 1.5–3 mg | Oral | ||
| DOB | Psychedelic | 45 | 18–30 hours | 24 | 1–3 g | Oral | ||
| Indole alkaloid | Ibogaine | Dissociative psychedelic | 80 | 18–36 hours | 26 | 1–1.5 g | Oral |